3月28日股市必读：迪安诊断（300244）董秘有最新回复

Core Viewpoint - The company, Dian Diagnostics, is recognized as a leading third-party medical diagnostics enterprise in China, with a significant accumulation of medical data and a leading position in the application of this data in the healthcare sector [2]. Group 1: Company Performance - As of March 28, 2025, Dian Diagnostics' stock closed at 15.88 yuan, down 1.12%, with a turnover rate of 3.04%, a trading volume of 152,400 shares, and a transaction value of 244 million yuan [1]. - On the same day, the net inflow of main funds was 6.45 million yuan, accounting for 2.64% of the total transaction value [3]. Group 2: Strategic Initiatives - The company is focused on integrating cutting-edge technologies, including robotics and brain-computer interface applications, into its diagnostic services to enhance efficiency and precision for patients [2]. - In 2024, the company repurchased nearly 200 million yuan worth of stock, with plans for stock incentive programs or potential cancellation [2].